Ku 0063794






42 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 19402821 Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR). Biochem J 2009 Jun 12 9
2 20884880 The mechanical stress-activated serum-, glucocorticoid-regulated kinase 1 contributes to neointima formation in vein grafts. Circ Res 2010 Nov 12 1
3 21956113 Mechanical regulation of glycogen synthase kinase 3β (GSK3β) in mesenchymal stem cells is dependent on Akt protein serine 473 phosphorylation via mTORC2 protein. J Biol Chem 2011 Nov 11 1
4 22223645 Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kinetics. J Biol Chem 2012 Mar 23 1
5 22415236 The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition. Br J Cancer 2012 Apr 10 1
6 22452883 Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin. Mol Cancer Res 2012 Jun 2
7 22619175 Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase/Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20-like kinase 1. J Biol Chem 2012 Jul 6 4
8 22885370 Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levels. Oncotarget 2012 Aug 1
9 23303455 Potent dual inhibitors of TORC1 and TORC2 complexes (KU-0063794 and KU-0068650) demonstrate in vitro and ex vivo anti-keloid scar activity. J Invest Dermatol 2013 May 3
10 23349989 A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models. PLoS One 2013 3
11 23437362 Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells. PLoS One 2013 2
12 23661091 mTOR pathway and Ca²⁺ stores mobilization in aged smooth muscle cells. Aging (Albany NY) 2013 May 3
13 23840605 Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines. PLoS One 2013 1
14 23874880 Targeting mTOR to overcome epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small cell lung cancer cells. PLoS One 2013 5
15 23940704 Requirement for the eIF4E binding proteins for the synergistic down-regulation of protein synthesis by hypertonic conditions and mTOR inhibition. PLoS One 2013 3
16 23958999 Nitric oxide regulates AKT phosphorylation and nuclear translocation in cultured retinal cells. Cell Signal 2013 Dec 3
17 24036423 Short term exposure to elevated levels of leptin reduces proximal tubule cell metabolic activity. Mol Cell Endocrinol 2014 Jan 25 5
18 24800098 Differential Role of Rapamycin and Torin/KU63794 in Inflammatory Response of 264.7 RAW Macrophages Stimulated by CA-MRSA. Int J Inflam 2014 1
19 25393730 Mammalian target of rapamycin complex 2 signaling pathway regulates transient receptor potential cation channel 6 in podocytes. PLoS One 2014 2
20 25618298 Significance of 4E-binding protein 1 as a therapeutic target for invasive urothelial carcinoma of the bladder. Urol Oncol 2015 Apr 1
21 26148118 Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines. PLoS One 2015 1
22 26278819 Autophagy inhibition sensitizes KU-0063794-mediated anti-HepG2 hepatocellular carcinoma cell activity in vitro and in vivo. Biochem Biophys Res Commun 2015 Sep 25 1
23 26960330 KU0063794, a Dual mTORC1 and mTORC2 Inhibitor, Reduces Neural Tissue Damage and Locomotor Impairment After Spinal Cord Injury in Mice. Mol Neurobiol 2017 May 3
24 27014314 Target of Rapamycin Is a Key Player for Auxin Signaling Transduction in Arabidopsis. Front Plant Sci 2016 2
25 27935857 Potentiation of the anticancer effects of everolimus using a dual mTORC1/2 inhibitor in hepatocellular carcinoma cells. Oncotarget 2017 Jan 10 1
26 27960162 The mTORC2/Akt/NFκB Pathway-Mediated Activation of TRPC6 Participates in Adriamycin-Induced Podocyte Apoptosis. Cell Physiol Biochem 2016 1
27 28396518 Rapamycin efficiently promotes cardiac differentiation of mouse embryonic stem cells. Biosci Rep 2017 Jun 30 2
28 28410220 Reprogramming induced by isoliquiritigenin diminishes melanoma cachexia through mTORC2-AKT-GSK3β signaling. Oncotarget 2017 May 23 2
29 28427860 Differential mTOR pathway profiles in bladder cancer cell line subtypes to predict sensitivity to mTOR inhibition. Urol Oncol 2017 Oct 2
30 28553309 The TOR Pathway Is Involved in Adventitious Root Formation in <i>Arabidopsis</i> and Potato. Front Plant Sci 2017 2
31 28915623 Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancer. Oncotarget 2017 Aug 22 1
32 29121714 Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy. Cancer Res Treat 2018 Jul 2
33 30906437 Role of mTOR signaling in the regulation of high glucose-induced podocyte injury. Exp Ther Med 2019 Apr 3
34 31499159 mTORC1 inhibition attenuates necroptosis through RIP1 inhibition-mediated TFEB activation. Biochim Biophys Acta Mol Basis Dis 2019 Dec 1 2
35 31726709 A Newly Established Murine Cell Line as a Model for Hepatocellular Cancer in Non-Alcoholic Steatohepatitis. Int J Mol Sci 2019 Nov 12 1
36 32736679 The role of PI3K/Akt/mTOR signaling in dose-dependent biphasic effects of glycine on vascular development. Biochem Biophys Res Commun 2020 Aug 27 2
37 32851605 Prevention of Akt phosphorylation is a key to targeting cancer stem-like cells by mTOR inhibition. Hum Cell 2020 Oct 3
38 32879215 β-Estradiol Enhanced Secretion of Lipoprotein Lipase from Mouse Mammary Tumor FM3A Cells. Biol Pharm Bull 2020 1
39 33799789 Combining Everolimus and Ku0063794 Promotes Apoptosis of Hepatocellular Carcinoma Cells via Reduced Autophagy Resulting from Diminished Expression of miR-4790-3p. Int J Mol Sci 2021 Mar 11 3
40 33831291 Potentiation of the Anticancer Effects by Combining Docetaxel with Ku-0063794 against Triple-Negative Breast Cancer Cells. Cancer Res Treat 2022 Jan 3
41 34245104 The inhibition of mammalian target of rapamycin (mTOR) in improving inflammatory response after traumatic brain injury. J Cell Mol Med 2021 Aug 1
42 35400284 Matrine Combined with Mammalian Target of Rapamycin Inhibitor Enhances Anti-Tumor Efficacy of dendritic cell Vaccines in hepatocellular carcinoma. Bioengineered 2022 Apr 1